Oxprenolol

Peptide Sequence: human 5-OxoETE receptor C-terminal amino acids 408-423 (KVQGEVSLEKEGSSQG) To be used in conjunction with Cayman&rsquos 5-OxoETE Receptor polyclonal antibody (Catalog No. 100025) to block protein-antibody complex formation during

An isomer of hypoxanthine that inhibits xanthine oxidoreductase (IC50 values between 0.2 and 50 &muM) lowers serum and urinary uric acid levels in vivo and is used to treat gout and hyperuricemia.

An isomer of hypoxanthine that inhibits xanthine oxidoreductase (IC50 values between 0.2 and 50 &muM) lowers serum and urinary uric acid levels in vivo and is used to treat gout and hyperuricemia.

An isomer of hypoxanthine that inhibits xanthine oxidoreductase (IC50 values between 0.2 and 50 &muM) lowers serum and urinary uric acid levels in vivo and is used to treat gout and hyperuricemia.

InformationAlmorexant HCl (ACT-078573) is an orally active, dualorexin receptorantagonist withIC50of 6.6 nM and 3.4 nM for OX1 and OX2 receptor, respectively. Phase 3.In vitroAlmorexant inhibits the increase in intracellular Ca2+ induced by 10 nM

InformationAlmorexant HCl (ACT-078573) is an orally active, dualorexin receptorantagonist withIC50of 6.6 nM and 3.4 nM for OX1 and OX2 receptor, respectively. Phase 3.TargetsOX2 receptor : OX1 receptor 3.4 nM: 6.6 nMIn vitroAlmorexant inhibits the

InformationAlmorexant HCl (ACT-078573) is an orally active, dualorexin receptorantagonist withIC50of 6.6 nM and 3.4 nM for OX1 and OX2 receptor, respectively. Phase 3.TargetsOX2 receptor : OX1 receptor 3.4 nM: 6.6 nMIn vitroAlmorexant inhibits the

InformationAlmorexant HCl (ACT-078573) is an orally active, dualorexin receptorantagonist withIC50of 6.6 nM and 3.4 nM for OX1 and OX2 receptor, respectively. Phase 3.TargetsOX2 receptor : OX1 receptor 3.4 nM: 6.6 nMIn vitroAlmorexant inhibits the

Anti-MTERF2 mitochondrial transcription termination factor 2

Anti-MTERF2 mitochondrial transcription termination factor 2

Anti-OXGR1 oxoglutarate (alpha-ketoglutarate) receptor 1, 10

Rat anti Mouse CD200/OX2 Antibody, Monoclonal (OX-90), could be used for in vivo CD200 blockade, in vitro CD200 blockade, IHC, ICC, IF, Flow and so on.